CN
CN
CN
Newsroom


Corporate News, Science and Technology, Resource Download

1-21 of 185 result

News Sep 09, 2024

Join Porton and Industry Elites at Pharma Crystallization Summit 2024!

The Full Agenda for the PCS 2024 is Now Available.

News Aug 27, 2024

Connect with Porton at CPhI Europe 2024 @ Booth 5C17

Early bird registration will close on September 5th, 2024

News Aug 13, 2024

The 5th Pharma Crystallization Summit is coming this September!

Early bird registration will close on September 5th, 2024

News Jul 19, 2024

Porton Passed FDA cGMP Inspection with No Action Indicated(NAI)

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

NewslettersJul 07, 2024

Porton Newsletter | Q2 2024 Recap

Porton Pharma Solutions Embark on The Next Frontier in Mengeš, Slovenia. Announcement of New GMP HPAPI Lab and Integrated DS-DP Facilities at Porton J-STAR. Porton can provide one-stop CDMO services from PCC to IND and GMP clinical supply of ADC drugs for global pharmaceutical companies.

News Jul 05, 2024

Technology-Driven | Porton's Crystallization Team and Genentech Jointly Published Breakthrough Results in 《Pharmaceutical Research》

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News Jun 29, 2024

Porton Experts Invited to Participate in the University of Perugia Master PRO-API Program, Aiding in the Training of Green Process Chemistry Professionals

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

News Jun 28, 2024

Porton J-STAR and Enabling Technologies Consortium Collaboration on Co-processing Platform Technology Development

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

Porton will be Participating in Biotech Outsourcing Strategies Events this June

News Jun 06, 2024

Porton will be Participating in Biotech Outsourcing Strategies Events this June

STRATEGIC EXPANSIONS FOR CUSTOMER-CENTRIC & GLOBAL SOLUTIONS

Become part of Porton's community to access personalized insights and resources.
Subscribe for the Newsletter
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

This website provides information on products tailored for a diverse audience and may include product details or information that are not readily accessible or valid in your country. Please note that we do not accept any responsibility for accessing such information in a manner that may violate any legal processes, regulations, registrations, or usage guidelines in your country of origin.

Become part of Porton's community to access personalized insights and resources.
Submit
By clicking “Subscribe,” you acknowledge that you have read and agree to our Legal Disclaimer, Terms of Use, and Privacy & Cookie Policy. Porton will use the contact information you provide to communicate with you about our products, services, and other relevant updates. You may unsubscribe at any time. For more information about how we protect your privacy and manage your communication preferences, please review our Privacy & Cookie Policy.

ⓒ 2025 PORTON Legal Notices | Porton Privacy

US: (609) 860-1300
CN: (86) 23-8608-3200